# Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine

> **NCT04207385** · PHASE4 · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 160 (estimated)

## Conditions studied

- Depression

## Interventions

- **DIAGNOSTIC_TEST:** pharmacogenomics
- **DIAGNOSTIC_TEST:** pharmacogenomics & therapeutic drug monitoring
- **DRUG:** Venlafaxine

## Key facts

- **NCT ID:** NCT04207385
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-11-20
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2019-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04207385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04207385, "Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04207385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*